From: Pediatric vs. adult stroke: comparative study in a tertiary referral hospital, Cairo, Egypt
Clinical presentations | Pediatric group 19Â Patients | Adult group 27Â Patients | p |
---|---|---|---|
Diffuse manifestations | Â | Â | Â |
 Headache | 13 (68.4%) | 13 (48.1%) | 0.172 |
 Vomiting | 9 (47.4%) | 8 (29.6%) | 0.220 |
 Seizure | 9 (47.4%) | 3 (11.1%) | 0.006* |
 Neck stiffness | 4 (21.1%) | 4 (14.8%) | 0.583 |
 Fever | 1 (5.3%) | 0 (0.0%) | 0.228 |
 Altered conscious level | 4 (21.1%) | 8 (29.6%) | 0.514 |
 Dizziness | 6 (31.6%) | 6 (22.2%) | 0.477 |
Focal manifestations | Â | Â | Â |
 Aphasia | 2 (10.5%) | 5 (18.5%) | 0.457 |
 Dysarthria | 1 (5.3%) | 13 (48.1%) | 0.002* |
 Neurologic–ophthalmologic signsa | 4 (21.1%) | 2 (7.4%) | 0.176 |
 Facial palsy | 4 (21.1%) | 13 (48.1%) | 0.061 |
 Ataxia/ gait abnormality | 3 (15.8%) | 2 (7.4%) | 0.368 |
 Hemiparesis | 9 (47.4%) | 16 (59.3%) | 0.425 |
 Hemianesthesia | 7 (36.8%) | 14 (51.9%) | 0.314 |
NIHSS, PedNIHSS | Â | Â | Â |
 Mild (1–4) | 4(21.0%) | 8 (29.6%) | 0.004* |
 Moderate (5–15) | 8 (42.1%) | 15 (55.6%) | |
 Moderate to severe (16–20) | 0 (0.0%) | 4 (14.8%) | |
 Severe (21–42) | 0 (0.0%) | 0 (0.0%) |